NEW YORK, NY / ACCESSWIRE / September 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of BrightSpring Health Services, Inc. ("BrightSpring Health Services, Inc.") (NASDAQ:BTSG) concerning possible violations of federal securities laws. BrightSpring conducted its initial public offering ("IPO") of 53,333,334 shares of common stock priced at $13.00 per share on or around January 25, 2024.
NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of BrightSpring Health Services, Inc. ("BrightSpring Health Services, Inc.") (NASDAQ:BTSG) concerning possible violations of federal securities laws. BrightSpring conducted its initial public offering ("IPO") of 53,333,334 shares of common stock priced at $13.00 per share on or around January 25, 2024.
NEW YORK, NY / ACCESSWIRE / September 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of BrightSpring Health Services, Inc. ("BrightSpring Health Services, Inc.") (NASDAQ:BTSG) concerning possible violations of federal securities laws. BrightSpring conducted its initial public offering ("IPO") of 53,333,334 shares of common stock priced at $13.00 per share on or around January 25, 2024.
NEW YORK, NY / ACCESSWIRE / September 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of BrightSpring Health Services, Inc. ("BrightSpring Health Services, Inc.") (NASDAQ:BTSG) concerning possible violations of federal securities laws. BrightSpring conducted its initial public offering ("IPO") of 53,333,334 shares of common stock priced at $13.00 per share on or around January 25, 2024.
NEW YORK, NY / ACCESSWIRE / September 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of BrightSpring Health Services, Inc. ("BrightSpring Health Services, Inc.") (NASDAQ:BTSG) concerning possible violations of federal securities laws. BrightSpring conducted its initial public offering ("IPO") of 53,333,334 shares of common stock priced at $13.00 per share on or around January 25, 2024.
NEW YORK, NY / ACCESSWIRE / September 7, 2024 / Pomerantz LLP is investigating claims on behalf of investors of BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of BrightSpring Health Services, Inc. ("BrightSpring Health Services, Inc.") (NASDAQ:BTSG) concerning possible violations of federal securities laws. BrightSpring conducted its initial public offering ("IPO") of 53,333,334 shares of common stock priced at $13.00 per share on or around January 25, 2024.
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / September 4, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of BrightSpring Health Services, Inc. ("BrightSpring Health Services, Inc.") (NASDAQ:BTSG) concerning possible violations of federal securities laws. BrightSpring conducted its initial public offering ("IPO") of 53,333,334 shares of common stock priced at $13.00 per share on or around January 25, 2024.
BrightSpring Health Services stock has underperformed since its IPO. The company aims to address important pain points in healthcare, such as reducing costs and providing seamless patient experiences. Despite a potential double-digit upside, caution is advised due to erratic financial performance, high debt, and uncertain growth projections.
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Pomerantz LLP is investigating claims on behalf of investors of BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / August 24, 2024 / Pomerantz LLP is investigating claims on behalf of investors of BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.